Safety and efficacy of direct oral anticoagulants in liver transplant recipients: initial experience

被引：0
|
作者：
Choudhary, N. S. [1 ]
Saraf, N. [1 ]
Dhampalwar, S. [1 ]
Rastogi, A. [1 ]
Bhangui, P. [1 ]
Gupta, A. [1 ]
Yadav, K. [1 ]
Valappil, F. K. [1 ]
Chaudhary, S. [1 ]
Soin, A. S. [1 ]
机构：
[1] Medanta Medicity, Inst Liver Transplantat & Regenerat Med, Gurugram, India
来源：
TRANSPLANTATION | 2023年 / 107卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
eP-190
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [41] Characterization of direct oral anticoagulants use in adult hematopoietic stem cell transplant recipients
    Claire Yang
    Fatima Khan
    Courtney MacDonald
    Julie Guglielmo
    Mimi Lo
    Rebecca Young
    Marisela Tan Banez
    Lily Huang
    Rosalyn Nguyen
    Stephen Kang
    Ila M. Saunders
    [J]. Journal of Thrombosis and Thrombolysis, 2024, 57 : 293 - 301
  • [42] Characterization of direct oral anticoagulants use in adult hematopoietic stem cell transplant recipients
    Yang, Claire
    Khan, Fatima
    Macdonald, Courtney
    Guglielmo, Julie
    Lo, Mimi
    Young, Rebecca
    Banez, Marisela Tan
    Huang, Lily
    Nguyen, Rosalyn
    Kang, Stephen
    Saunders, Ila M.
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2024, 57 (02) : 293 - 301
  • [43] Effect of the Direct Oral Anticoagulants Rivaroxaban and Apixaban on the Disposition of Calcineurin Inhibitors in Transplant Recipients
    Vanhove, Thomas
    Spriet, Isabel
    Annaert, Pieter
    Maertens, Johan
    Van Cleemput, Johan
    Vos, Robin
    Kuypers, Dirk
    [J]. THERAPEUTIC DRUG MONITORING, 2017, 39 (01) : 77 - 82
  • [44] EFFICACY AND SAFETY OF DIRECT ACTING ANTIVIRALS IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C - A LARGE INTEGRATED HEALTH CARE CENTER EXPERIENCE
    Verma, Dhruv
    Mittal, Rasham
    Sahota, Amandeep K.
    [J]. HEPATOLOGY, 2019, 70 : 965A - 965A
  • [45] Safety of direct oral anticoagulants (DOACs) in patients with advanced liver disease
    Semmler, Georg
    Pomej, Katharina
    Bauer, David J. M.
    Balcar, Lorenz
    Simbrunner, Benedikt
    Binter, Teresa
    Hartl, Lukas
    Becker, Jeanette
    Pinter, Matthias
    Quehenberger, Peter
    Trauner, Michael
    Mandorfer, Mattias
    Lisman, Ton
    Reiberger, Thomas
    Scheiner, Bernhard
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S374 - S375
  • [46] Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
    Gane, E
    Saliba, F
    Valdecasas, GJC
    OGrady, J
    Pescovitz, MD
    Lyman, S
    Robinson, CA
    [J]. LANCET, 1997, 350 (9093): : 1729 - 1733
  • [47] Valganciclovir for CMV prophylaxis in liver transplant recipients: An initial experience.
    Berkman, SC
    Ashcraft, E
    Baillie, GM
    Taber, D
    Lin, A
    Rogers, J
    Baliga, P
    Chavin, KD
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 358 - 358
  • [48] Direct oral anticoagulants: our experience
    Santoro, R.
    Minici, R.
    Iannaccaro, P.
    Morgione, S.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 635 - 635
  • [49] SAFETY AND EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ADVANCED LIVER DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Ronca, Vincenzo
    Menichelli, Danilo
    Pignatelli, Pasquale
    Podda, Gian Marco
    [J]. HEPATOLOGY, 2020, 72 : 1150 - 1150
  • [50] Efficacy and pharmacokinetics of tacrolimus oral suspension in pediatric liver transplant recipients
    Reding, R
    Sokal, E
    Paul, K
    Janssen, M
    Evrard, V
    Wilmotte, L
    Chardot, C
    Otte, JB
    Wallemacq, P
    [J]. PEDIATRIC TRANSPLANTATION, 2002, 6 (02) : 124 - 126
12345